This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd.. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations of Xiaosong Mao in Pharmaceutical Research
Introduction
Xiaosong Mao is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of prodrug compounds. His work focuses on enhancing the efficacy and solubility of existing medications.
Latest Patents
Xiaosong Mao holds a patent for a prodrug compound of levosimendan, which includes a preparation method and its uses. This invention addresses the limitations of levosimendan, such as poor water solubility. The prodrug compound exhibits an ideal pharmacokinetic profile and shows excellent prospects for medicament development.
Career Highlights
Mao is affiliated with the Beijing Chenguang Tongchuang Pharmaceutical Research Institute Co., Ltd. His work at this institute has been pivotal in advancing pharmaceutical innovations. He has dedicated his career to improving drug formulations and enhancing therapeutic outcomes.
Collaborations
Xiaosong Mao has collaborated with notable colleagues, including Shaolin Huang and Changbin Guo. These partnerships have fostered a collaborative environment that encourages innovation and research excellence.
Conclusion
Xiaosong Mao's contributions to pharmaceutical research, particularly through his patent on levosimendan prodrug compounds, highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in medication development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile